Evidence map›Paper›PMID 42389559›Full record

ArticleEcancermedicalscience2026

Establishment of the first bone marrow transplant program in francophone sub-Saharan Africa: clinical case and future perspectives.

Elhadji Daouda Niang, Seynabou Fall, Sokhna Aissatou Toure, Marieme Lolita Camara, Modou Moustapha Ciss, Adjaratou Tiane Niang, Khadim Sarr, Amy Thiam, Fatou Samba Diago Ndiaye

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elhadji Daouda NiangDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Seynabou FallDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Sokhna Aissatou ToureDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Marieme Lolita CamaraDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Modou Moustapha CissDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Adjaratou Tiane NiangDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Khadim SarrDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Amy ThiamDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.
Fatou Samba Diago NdiayeDepartment of Hematology, University of Cheikh Anta Diop, Dakar, BP 5005 Dakar-Fann, BP 5005 Dakar-Fann, Senegal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Haematopoietic stem cell transplantation (HSCT) offers curative potential for several malignant and non-malignant hematologic disorders. Despite its proven efficacy, access to HSCT in sub-Saharan Africa remains limited, especially in francophone countries, due to the lack of infrastructure, cryobiology facilities and trained personnel. Senegal recently launched a national initiative to establish its first HSCT program. Case report of the first autologous stem cell transplant in Senegal: We report the first autologous HSCT performed in Senegal in February 2025 at Dalal Jamm University Hospital, in a 51-year-old man diagnosed with high-risk IgA-lambda multiple myeloma (ISS stage III, del17p). Mobilisation was achieved using filgrastim (10 µg/kg/day for 7 days). A total of 2.8 × 10⁶ CD34⁺ cells/kg were collected by apheresis and stored at 4°C for 24 hours without cryopreservation. Conditioning consisted of high-dose intravenous melphalan (200 mg/m Conclusion: This first non-cryopreserved autologous HSCT in Senegal demonstrates the feasibility, safety and cost-effectiveness of transplantation under resource-limited conditions. Establishing local cryopreservation and molecular diagnostic capabilities will be essential to enable tandem and allogeneic HSCT, ensuring sustainability and regional self-sufficiency in advanced hematologic care.

Indexed as

Africaconditioningmultiple myelomatransplantation

Identifiers

PMID42389559
PMCPMC13319353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.